ESYN EnerSyn Global Inc.
Wholesale-Drugs, Proprietaries & Druggists' Sundries · Nasdaq · SEC CIK 1897245 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-76.8%
TTM net income YoY-391.3%
TTM EPS YoY-244.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin50.7%
Operating margin—
Net margin-2,095.4%
FCF margin-327.6%
EBITDA margin—
Returns
ROE-69.0%
ROA-46.6%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets28.5%
Debt / equity0.00x
Current ratio3.29x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.16x
Accruals ratio-39.3%
Payout ratio—
Capex / revenue0.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $72,646 | $64,200 | $64,200 | $54,560 | $206,778 | $310,391 | $295,197 | $287,062 |
| Cost of revenue | $50,267 | $43,836 | $16,912 | $14,899 | $178,933 | $266,314 | $147,603 | $173,285 |
| Gross profit | $22,379 | $20,364 | $47,288 | $39,661 | $27,845 | $44,077 | $147,594 | $113,777 |
| SG&A expense | $3.10M | $249,063 | $672,202 | $2.05M | $229,239 | $383,868 | $664,242 | $375,302 |
| Interest expense | $475 | $2,337 | $9,132 | -$59,540 | $32,127 | $29,529 | $50,126 | $16,797 |
| Pretax income | -$3.00M | $210,657 | -$626,773 | -$1.95M | -$295,094 | $75,977 | -$531,155 | -$329,201 |
| Income tax | — | — | — | $0 | $4,524 | $0 | $42,948 | — |
| Net income | -$3.00M | $211,965 | -$626,197 | -$1.95M | -$291,004 | $83,389 | -$565,131 | -$317,478 |
| EPS (basic) | -0.15 | 0.03 | -0.08 | — | -0.04 | 0.01 | -0.09 | — |
| EPS (diluted) | -0.15 | 0.03 | -0.08 | — | -0.04 | 0.01 | -0.09 | — |
| Weighted avg. shares (diluted) | 20.16M | 7.54M | 7.48M | — | 6.48M | 6.48M | 6.42M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $10.87M | $1.51M | $1.46M | $2.09M | $2.90M | $3.73M | $4.18M | $4.34M |
| Short-term investments | $67,919 | $113,687 | $99,615 | $84,466 | — | — | $101,125 | $13,272 |
| Receivables | $2,778 | — | — | $3,324 | — | — | — | — |
| Inventory | $1,065 | $1,514 | $1,085 | $1,057 | $1,113 | $6,369 | $2,585 | $1,574 |
| Current assets | $16.50M | $2.97M | $2.45M | $2.97M | $3.86M | $9.18M | $5.91M | $5.47M |
| PP&E, net | $14,897 | $14,655 | $16,933 | $19,153 | $21,844 | $31,876 | $32,133 | $33,588 |
| Goodwill | — | — | — | $116,648 | $122,482 | $77,480 | — | $0 |
| Total assets | $17.82M | $4.51M | $4.21M | $4.57M | $5.18M | $10.60M | $6.53M | $6.41M |
| Current liabilities | $5.01M | $1.64M | $1.53M | $1.28M | $2.25M | $7.15M | $2.66M | $3.31M |
| Total liabilities | $5.07M | $1.71M | $2.13M | $1.88M | $2.28M | $7.20M | $2.84M | $3.53M |
| Shareholders' equity | $12.69M | $2.73M | $2.01M | $2.62M | $2.84M | $3.23M | $3.59M | $2.77M |
| Shares outstanding | 29.73M | 7.73M | 7.48M | 7.48M | 6.48M | 6.48M | 6.48M | 5.59M |
| Cash flow statement | ||||||||
| Operating cash flow | -$99,461 | $478,008 | -$192,539 | -$1.02M | -$199,902 | $26,909 | -$555,333 | -$255,926 |
| Capital expenditure | $635 | -$2 | $766 | $87 | $18,006 | — | — | $291 |
| Free cash flow | -$100,096 | $478,010 | -$193,305 | -$1.02M | -$217,908 | — | — | -$256,217 |
| Investing cash flow | $29,669 | -$100,953 | -$305,416 | -$173,405 | -$273,758 | -$441,523 | -$300,000 | $341 |
| Financing cash flow | $9.47M | -$340,540 | -$148,432 | -$268,593 | $624,450 | -$77,372 | $656,229 | $3.65M |
| Depreciation & amortization | $2,255 | $2,047 | $2,091 | -$3,387 | $16,219 | $3,380 | $3,282 | $2,643 |
| Share buybacks | — | — | — | — | — | — | — | $1 |
Free plan shows the latest 8 periods; Pro shows all 23 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.